ALNY
Alnylam Pharmaceuticals Inc
Price:  
162.81 
USD
Volume:  
1,174,341.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Alnylam WACC - Weighted Average Cost of Capital

The WACC of Alnylam Pharmaceuticals Inc (ALNY) is 9.1%.

The Cost of Equity of Alnylam Pharmaceuticals Inc (ALNY) is 9.25%.
The Cost of Debt of Alnylam Pharmaceuticals Inc (ALNY) is 7.00%.

Range Selected
Cost of equity 8.00% - 10.50% 9.25%
Tax rate 0.20% - 0.30% 0.25%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.9% - 10.4% 9.1%
WACC

Alnylam WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.82 0.96
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.00% 10.50%
Tax rate 0.20% 0.30%
Debt/Equity ratio 0.05 0.05
Cost of debt 7.00% 7.00%
After-tax WACC 7.9% 10.4%
Selected WACC 9.1%